Join the 3rd"Let's Talk MPTs" webinar; toxicity study considerations for MPT and HIV prevention R&D

The Initiative for Multipurpose Prevention Technologies (IMPT) continues it's "Let's Talk" series this month with a discussion that aims to provide MPT and HIV prevention product developers and other stakeholders an overview of strategies to assess the toxicity of MPT drug candidates and describe the potential toxicity risks of pharmaceutical substances to the female reproductive tract.

This discussion will feature:

• Tom Moench, MD Vice President of Clinical Development at Mucommune

• Miles Brennan, PhD Chief Science Officer at ZabBio

Register now to join the event this week on Thursday, May 27 at 11am EDT!

Did you miss the last two discussions in the IMPT's "Let's Talk" series? Watch the recordings now:

• The Role of Cervicovaginal Microbiota on Contraceptive and MPT Development, read more here

• Integrating Socio-behavioral & Market Research into MPT R&D, read more here

Access more amazing webinars and discussions like these by visiting and subscribing to the CTI Exchange YouTube channel.